Skincare Brand Glowbar closes USD 10 million growth funding
New York, USA-based skincare brand Glowbar announced the closure of its growth funding at USD 10 million. The company announced the closure on January 4, 2022. Salt Lake City-based firm Peterson Parkers led the investment for the company. Purpose of financing for Glowbar With the latest investment, Glowbar seeks to double its studio count by the end of 2023. In addition...
Oregon-based manufacturing startup Puffin Drinkwear closes Series A funding round
Jan. 4, 2023 — Puffin Drinkwear, which creates personality-infused gear for your drink to wear, said that it had raised a Series A round-headed by Village Family Capital and Jim Collis of Colfam Management. Arianna Moore, the company's new CFO, will join the Puffin Drinkwear team, bringing considerable financial leadership expertise with Private Equity-backed firms. This expansion investment will...
Miami-based healthcare platform Ostro closes Series B funding round
MIAMI, January 4, 2023 – Ostro, a leading healthcare interaction platform for consumers and HCPs, celebrated several key milestones in 2022, including yearly revenue growth of more than 250%, Series B investment, a new website, and brand design, and a Forbes mention for co-founder Ahmed Elsayyad. Chase Feiger, MD, Ostro's CEO remarked : "I've never been more excited about Ostro's future...
SirionLabs raises an additional USD 25 million financing in Series D
Seattle, USA-based global leader in artificial intelligence (AI)-powered contract lifecycle management (CLM), SirionLabs raised an additional USD 25 million in financing. The Series D round took place on January 3, 2023. The company's Series D funding now amounts to USD 110 million. Brookfield Growth led the funding for the firm. Purpose of financing for SirionLabs With the latest capital injection, the...
Lending firm SarvaGram closes its Series C funding at USD 35 million
India-based rural household-focused lending and distribution platform, SarvaGram closed its Series C round at USD 35 million. The company announced the closure on January 3, 2023. Venture capital fund Elevar Equity led the financing for the firm. Meanwhile, Elevation Capital, Temasek and TVS Capital Funds joined in the funding. Purpose of financing for SarvaGram With the latest proceeds from the Series...
London-based pharma company Actimed Therapeutics Ltd closes second tranche of EUR 10 million in seed funding
LONDON, Jan. 4, 2023 — Actimed Therapeutics Ltd, a clinical-stage specialty pharmaceutical company based in the United Kingdom focused on bringing innovation to the treatment of cancer cachexia, a significant unmet medical need for cancer patients and other muscle wasting disorders, has completed its second and final £5 million seed financing tranche. Mankind Pharma, an Indian pharmaceutical business, invested...
Paris-based robotics startup Ganymed Robotics raises additional EUR 15 million in Series B funding
PARIS—- Ganymed Robotics, a provider of computer vision software and robotics technology for orthopedic surgeons, announced an additional EUR 15 million closing to its Series B, increasing the total Series B sum to €36 million. The European Innovation Council Fund and Cap Horn spend €14 million through their Accelerator Program. The French national investment bank, Bpifrance, issued a €1 million...
USA-based Ethos invests USD 12 million investment in REM People
Dubai and Istanbul, Turkey-based REM People received USD 12 million investment from Ethos Asset Management. The company announced the investment on January 3, 2022. USA-based project finance and investment company Ethos Asset Management also announced the partnership with the said firm. Purpose of investment for REM People REM People intends to use the latest capital injection to expand its international network...
USA-based Kopis acquires Intelice’s ERP Group
South Carolina, USA-based tech firm specializing in enterprise-level app development and Enterprise Resource Planning (ERP) services, Kopis acquired ERP Group of Intelice. The company announced the acquisition on January 2, 2023. However, it did not disclose the terms of the purchase. Purpose of purchase of Kopis With the recent acquisition of the ERP group, Kopis intends to expand its number of...
Cambridge-based pharmaceutical based firm Apnimed Inc raises USD 79.75 million in Series C funding
CAMBRIDGE, MASSACHUSETTS— Apnimed, Inc., the clinical-stage pharmaceutical company focused on developing the oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, announced today that it has raised USD 79.75 million in an oversubscribed financing round, bringing its total Series C funding to USD 142.25 million. Alpha Wave Ventures led the financing, which also included...
